title: [Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].
abstract: BACKGROUND
  During the past years the provision of mental healthcare for adults with intellectual disabilities (ID) has repeatedly been criticized; however, the number of relevant studies is still relatively few.
  
  
  OBJECTIVE
  The aim of the present study was to identify determinants for utilization of mental healthcare services and prescription of psychotropic medication in adults with mild to moderate ID.
  
  
  METHODS
  Analyses were based on data from 417 adults with mild to moderate ID, which had been collected within the cross-sectional MEMENTA study in three different regions of Germany. Logistic regression analyses were conducted to identify clinical and sociodemographic variables as predictors of utilization of mental healthcare services (n = 282) and psychotropic medication (n = 351).
  
  
  RESULTS
  Utilization of healthcare services and psychotropic medication were both associated with mental disorders and problem behavior. In addition, the likelihood of being treated with psychotropic medication and antipsychotic drugs was higher in adults living in residential homes.
  
  
  CONCLUSIONS
  The findings indicate a lack of adherence to existing guidelines in the treatment of adults with ID living in residential homes.
authors.affiliation: Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum C. G. Carus der TU Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland. matthias.schuetzwohl@uniklinikum-dresden.de.
authors.forename: M
authors.initials: M
authors.lastname: Schützwohl
authors.affiliation: Arbeitsgruppe Versorgungsforschung, Zentralinstitut für Seelische Gesundheit, Medizinische Fakultät Mannheim/Universität Heidelberg, Heidelberg, Deutschland.
authors.forename: E
authors.initials: E
authors.lastname: Voss
authors.affiliation: Sektion Prozess-Ergebnisforschung, Klinik für Psychiatrie und Psychotherapie II, Universität Ulm, Ulm, Deutschland.
authors.forename: M
authors.initials: M
authors.lastname: Stiawa
authors.affiliation: Arbeitsgruppe Versorgungsforschung, Zentralinstitut für Seelische Gesundheit, Medizinische Fakultät Mannheim/Universität Heidelberg, Heidelberg, Deutschland.
authors.forename: H-J
authors.initials: HJ
authors.lastname: Salize
authors.affiliation: Sektion Prozess-Ergebnisforschung, Klinik für Psychiatrie und Psychotherapie II, Universität Ulm, Ulm, Deutschland.
authors.forename: B
authors.initials: B
authors.lastname: Puschner
authors.affiliation: Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum C. G. Carus der TU Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland.
authors.forename: A
authors.initials: A
authors.lastname: Koch
mesh_terms: D000328:Adult; D015897:Comorbidity; D003430:Cross-Sectional Studies; D004363:Drug Utilization / Q000706:statistics & numerical data; D005260:Female; D005858:Germany; D006801:Humans; D008607:Intellectual Disability / Q000145:classification / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D008297:Male; D001523:Mental Disorders / Q000145:classification / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology; D008875:Middle Aged; D010342:Patient Acceptance of Health Care / Q000523:psychology / Q000706:statistics & numerical data; D000066553:Problem Behavior / Q000523:psychology; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D013223:Statistics as Topic; D014600:Utilization Review / Q000706:statistics & numerical data
chemical_list: D011619:Psychotropic Drugs
keywords: Health care utilization; Problem behavior; Psychotropic drugs